SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARIAD Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
4474 134 0 ARIA
Emcee:  jaybe Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4149New commentary to Jan 14th Blood article on pona's impact with low-level mutjaybe-3/2/2016
4148Please correct me if my logic is flawed: since Denner and PP and the terrible AVidpok1-3/1/2016
4147Big divergence today between the IBB and Ariad. Who's buying and why. Is iVidpok1-2/29/2016
4146Since my recent post we are up about 20 percent from our low in the 4's. EiVidpok1-2/26/2016
4145I can't get out of my mind that Paris lit the spark that started the Trojan tom pope-2/23/2016
4144Listened to the conference call today and I liked PP's style. UnfortunateVidpok1-2/23/2016
4143 Presentation Title: AP32788, a potent, selective inhibitor of EGFR and HER2 oncBiomaven22/23/2016
4142True, the censorship over there is onerous but that's just the way it is. Vidpok1-2/17/2016
4141No doubt about it, we have a couple of green days and the douchebaggery on the HSullyInFL-2/17/2016
4140Sully, oil will undoubtedly rise once the producers come to an agreement to cutVidpok1-2/17/2016
4139Ariad has a great deal of IP and will bring its share of interest soon enough. SSullyInFL-2/17/2016
4138Since the recent 52 week low we are up 15 percent off the low. The IBB is up 10Vidpok1-2/17/2016
4137Drucker reported PON was effective in some TKI-resistant pts who exhibited no kimulanoon2007-2/13/2016
4136Jaybe's last post is the latest indication that the potential for Ponatinib Vidpok1-2/13/2016
4135New editorial on November Blood article regarding pona resistance... ..."tjaybe-2/12/2016
4134Thanks Jaybe.jesspro-2/12/2016
4133Vid, agree on all points. The global markets are a mess these days and their impSullyInFL-2/12/2016
4132Surprising to see dasatinib with highest VOE risk factor, makes me doubt the comjaybe12/11/2016
4131Jaybe, care to expound on the importance of this post/article for Ariad. TIA. sjesspro-2/11/2016
4130Hello Sully. Yes, I just got tired of all the hand wringing self pity by thoseVidpok1-2/11/2016
4129Hi Vid, wondered where you were, now I know. Wise choice for obvious reasons. ThSullyInFL-2/11/2016
4128Unfortunately I think macro issues are going to continue to affect the biotech sVidpok1-2/8/2016
4127Some stocks with high analyst targets $BCLI -($5)$,DSKX -($6), $OTIV - ($3), $HNjoegene-2/4/2016
4126So which, if any, of pona's IST's will read-out at ASCO? According to Ajaybe12/4/2016
4125Mayo Clinic uses AP20187 to help extend lifespan of mice... Actually a trans-gejaybe-2/3/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News